The global enteral feeding formulas market is highly consolidated, with the top 4 players holding more than half of the market share in 2015. A majority of the leading players in this market are based in developed countries across North America and Europe.
Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) were the leading market players in 2015. Abbott Laboratories (U.S.) is a market leader owing to its broad portfolio of enteral feeding formulas. The company has a substantial geographic footprint with strong sales and distribution networks. It invests considerably in R&D activities to add innovative technologies and products to its portfolio, which in turn helps it to strengthen its presence in this market. In July 2014, the company launched a new Similac Breastfeeding Supplement that is specially designed to enhance the levels of DHA, lutein, and vitamin E in breast milk. Nestlé S.A. (Switzerland) is also a major player in this market and has a strong geographic presence and a diversified portfolio of enteral feeding formulas, including a wide range of standard and disease-specific formulas. The expansion of the Nestlé Health Science Manufacturing Plant in Kasumigaura, Japan in June 2014 further strengthened its production capacity and its position in the enteral feeding formulas market. Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Food, LLC (U.S.), Meiji Holdings Co., Ltd. (Japan), Victus, Inc. (U.S.), and Global Health Products, Inc. (U.S.) are some other prominent players in this market.
The growth strategies adopted by the major players in the global enteral feeding formulas market were expansions, new product launches, partnerships agreements & collaborations, and acquisitions. A majority of the top market players have adopted new product launches and expansions as their key growth strategies.
